Week 9 : PD Flashcards
What is parkinsonism
clinical syndrome characterised by a disorder of movement consisting of tremor, rigidity, elements of bradykinesia, hypokinesia, akinesia and postural abnormalities
What is Parkinson’s disease
clinical syndrome of Parkinsonism associated with a distinctive pathology
Aetiology of parkinson’s
typically a slowly progressive degenerative disease
primarily related to a lack of dopamine
most common disease affecting the basal ganglia
epidemiology of parkinson’s disease
2nd most common neurological disease in Australia (following dementia)
M 1.5: 1 F
pathophysiology of parkinson’s disease
reduction in dopamine
- disturbance of the central dopaminergic pathway from the substantia nigra to the striatum
deep pigmentaton and neuronal loss in the substantia nigra
presence of lewy bodies with consequent changes to neural conduction in the nigrostriatal pathway
- BG, brainstem, spinal cord and cortex
pathophysiology of parkinson’s disease #2
idiopathic
a family hx is the strongest risk factor for the development of the disease
genetic mutations
rural residence is a significant risk factor for PD
positive association between PD and pesticides
negative association with cigarette smoking
genetic and environmental factors are now thought to interact and increase the risk of developing PD
diagnosis of PD
35% Misdiagnosed /mismanaged
primarily clinical diagnosis
- presence of bradykinesia and progressive reduction of speed amplitude of repetitive movements
- rigidity, resting tremor and/or postural instability
- absence of red flags
what are the four clinical subtypes of PD
earlier disease onset (<55 years)
tremor dominant
postural imbalances and gait disorder (PIGD)
disease progression, prognostic factors and mortality
high variability in impairments of functions, activity limitations and participation restriction
postural and axial symptoms evolve more rapidly than other motor features are appear to be the index of disease progression.
Hoehn and Yahr staging scale is used clinically to stage PD progression
it’s not linear
doesn’t include non-motor functioning
slide 11
MDT involved with PD
as many as 19 health professionals and institutions may be involved in one patient’s care
medication for PD
first choice in care
aims to correct the neurotransmitter imbalance within the basal ganglia circuity
PD frequently necessities multiple doses of multiple medications
current pharmacological management largely based on dopamine precursor levodopa and dopamine agonists
levodopa
gold standard : offers best symptomatic relief of rigidity, bradykinesia and tremor
dopamine agonists
often prescribed to alleviate other diabling complications such as restless legs, sleep fragmentation, early morning akinesia
Neurosurgery
thalamotomy
deep brain stimulator